Please use this identifier to cite or link to this item: https://doi.org/10.1007/s12185-018-2518-z
DC FieldValue
dc.titleOncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia
dc.contributor.authorTan, Tze King
dc.contributor.authorZhang, Chujing
dc.contributor.authorSanda, Takaomi
dc.date.accessioned2019-06-06T05:59:36Z
dc.date.available2019-06-06T05:59:36Z
dc.date.issued2019-01-01
dc.identifier.citationTan, Tze King, Zhang, Chujing, Sanda, Takaomi (2019-01-01). Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia. INTERNATIONAL JOURNAL OF HEMATOLOGY 109 (1) : 5-17. ScholarBank@NUS Repository. https://doi.org/10.1007/s12185-018-2518-z
dc.identifier.issn0925-5710
dc.identifier.issn1865-3774
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/155213
dc.description.abstract© 2018, The Japanese Society of Hematology. TAL1/SCL is a prime example of an oncogenic transcription factor that is abnormally expressed in acute leukemia due to the replacement of regulator elements. This gene has also been recognized as an essential regulator of hematopoiesis. TAL1 expression is strictly regulated in a lineage- and stage-specific manner. Such precise control is crucial for the switching of the transcriptional program. The misexpression of TAL1 in immature thymocytes leads to a widespread series of orchestrated downstream events that affect several different cellular machineries, resulting in a lethal consequence, namely T-cell acute lymphoblastic leukemia (T-ALL). In this article, we will discuss the transcriptional regulatory network and downstream target genes, including protein-coding genes and non-coding RNAs, controlled by TAL1 in normal hematopoiesis and T-cell leukemogenesis.
dc.language.isoen
dc.publisherSPRINGER JAPAN KK
dc.sourceElements
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectHematology
dc.subjectTAL1
dc.subjectT-cell acute lymphoblastic leukemia
dc.subjectTranscription factor
dc.subjectGENOME-WIDE ANALYSIS
dc.subjectLONG NONCODING RNAS
dc.subjectHEMATOPOIETIC STEM
dc.subjectGENE-EXPRESSION
dc.subjectCHROMOSOMAL TRANSLOCATION
dc.subjectTHYMOCYTE DEVELOPMENT
dc.subjectPATHWAY ACTIVATION
dc.subjectDIRECT TARGET
dc.subjectCYCLIN D3
dc.subjectC-MYC
dc.typeArticle
dc.date.updated2019-06-03T08:29:03Z
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.description.doi10.1007/s12185-018-2518-z
dc.description.sourcetitleINTERNATIONAL JOURNAL OF HEMATOLOGY
dc.description.volume109
dc.description.issue1
dc.description.page5-17
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
2019-Oncogenic_transciptional_program_driven_by-published.pdf948.14 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.